uniQure N.V. (NASDAQ: QURE)
$9.13
+0.4100 ( +4.70% ) 4.0M
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$9.13
Previous close
$8.72
Volume
4.0M
Market cap
$442.29M
Day range
$8.54 - $9.75
52 week range
$3.73 - $11.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 17, 2024 |
4 | Insider transactions | 1 | Jun 17, 2024 |
8-k | 8K-related | 15 | Jun 03, 2024 |
8-k | 8K-related | 15 | May 07, 2024 |
10-q | Quarterly Reports | 62 | May 07, 2024 |
ars | Annual reports | 1 | May 01, 2024 |
def | Proxies and info statements | 20 | Apr 24, 2024 |
8-k | 8K-related | 13 | Apr 12, 2024 |
pre | Proxies and info statements | 21 | Apr 12, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |